Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Microvascular Angina | 1 | 2017 | 19 | 0.71 | Why? |
| Arrhythmias, Cardiac | 6 | 2020 | 2510 | 0.70 | Why? |
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 56 | 0.68 | Why? |
| Defibrillators, Implantable | 5 | 2019 | 624 | 0.54 | Why? |
| Catheter Ablation | 3 | 2019 | 438 | 0.39 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.38 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.38 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.38 | Why? |
| Electrocardiography | 3 | 2020 | 3957 | 0.35 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.34 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.31 | Why? |
| Pacemaker, Artificial | 2 | 2019 | 431 | 0.26 | Why? |
| Death, Sudden, Cardiac | 2 | 2018 | 522 | 0.25 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.23 | Why? |
| Hypoxia | 3 | 2021 | 3626 | 0.22 | Why? |
| Electrophysiology | 1 | 2020 | 64 | 0.21 | Why? |
| Electronics, Medical | 1 | 2019 | 4 | 0.21 | Why? |
| Hospital Mortality | 3 | 2020 | 22087 | 0.21 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.20 | Why? |
| Cardiac Resynchronization Therapy | 2 | 2020 | 191 | 0.19 | Why? |
| Electrodes, Implanted | 1 | 2018 | 60 | 0.18 | Why? |
| Channelopathies | 1 | 2017 | 12 | 0.18 | Why? |
| Cardiac Resynchronization Therapy Devices | 1 | 2017 | 64 | 0.17 | Why? |
| Device Removal | 1 | 2018 | 221 | 0.16 | Why? |
| Administration, Oral | 2 | 2020 | 2340 | 0.15 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.15 | Why? |
| Italy | 10 | 2020 | 38444 | 0.15 | Why? |
| Electric Countershock | 1 | 2017 | 284 | 0.14 | Why? |
| Amiodarone | 1 | 2016 | 110 | 0.14 | Why? |
| Erythrocytes | 1 | 2020 | 617 | 0.14 | Why? |
| Myocardial Ischemia | 1 | 2020 | 781 | 0.13 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2021 | 1316 | 0.13 | Why? |
| Anti-Arrhythmia Agents | 1 | 2016 | 325 | 0.13 | Why? |
| Atrial Fibrillation | 2 | 2019 | 2320 | 0.12 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.12 | Why? |
| Cardiomyopathies | 1 | 2020 | 997 | 0.10 | Why? |
| Cerebrovascular Disorders | 1 | 2019 | 1040 | 0.10 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.10 | Why? |
| Registries | 5 | 2020 | 12327 | 0.10 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.10 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.10 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.08 | Why? |
| Heart Failure | 2 | 2020 | 6638 | 0.08 | Why? |
| Male | 15 | 2021 | 367725 | 0.08 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.08 | Why? |
| Humans | 23 | 2021 | 930598 | 0.08 | Why? |
| Female | 15 | 2021 | 380317 | 0.08 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.08 | Why? |
| Coronary Artery Disease | 1 | 2020 | 2570 | 0.07 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Retreatment | 1 | 2018 | 186 | 0.05 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2020 | 696 | 0.04 | Why? |
| Electromagnetic Fields | 1 | 2017 | 34 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Heart Atria | 1 | 2019 | 267 | 0.04 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 396 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Geography | 1 | 2019 | 1801 | 0.03 | Why? |
| Aspirin | 1 | 2020 | 1043 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.03 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Heart Ventricles | 1 | 2019 | 1139 | 0.03 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.02 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Cardiology | 1 | 2019 | 2873 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.02 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.01 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2016 | 17020 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |